Literature DB >> 25840917

Sinomenine and magnoflorine, major constituents of Sinomeni caulis et rhizoma, show potent protective effects against membrane damage induced by lysophosphatidylcholine in rat erythrocytes.

Hitoshi Sakumoto1, Yumiko Yokota, Gakushi Ishibashi, Shouta Maeda, Chihiro Hoshi, Haruyo Takano, Miki Kobayashi, Tadahiro Yahagi, Soichiro Ijiri, Iwao Sakakibara, Akiyoshi Hara.   

Abstract

The effects of the water extract of Sinomeni Caulis et Rhizoma (SCR-WE) and its major constituents, sinomenine (SIN) and magnoflorine (MAG), on moderate hemolysis induced by lysophosphatidylcholine (LPC) were investigated in rat erythrocytes and compared with the anti-hemolytic effects of lidocaine (LID) and propranolol (PRO) as reference drugs. LPC caused hemolysis at concentrations above the critical micelle concentration (CMC), and the concentration of LPC producing moderate hemolysis (60 %) was approximately 10 μM. SCR-WE at 1 ng/mL-100 μg/mL significantly inhibited the hemolysis induced by LPC. SIN and MAG attenuated LPC-induced hemolysis in a concentration-dependent manner from very low to high concentrations (1 nM-100 μM and 10 nM-100 μM, respectively). In contrast, the inhibiting effects of LID and PRO on LPC-induced hemolysis were observed at higher concentrations (1-100 μM) but not at lower concentrations (1-100 nM). Neither SIN nor MAG affected micelle formation of LPC, nor, at concentrations of 1 nM-1 μM, did they attenuate the hemolysis induced by osmotic imbalance (hypotonic hemolysis). Similarly, SCR-WE also did not modify micelle formation or hypotonic hemolysis, except at the highest concentration. These results suggest that SIN and MAG potently protect the erythrocyte membrane from LPC-induced damage and contribute to the beneficial action of SCR-WE. The protective effects of SIN and MAG are mediated by some mechanism other than prevention of micelle formation or protection of the erythrocyte membrane against osmotic imbalance.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25840917     DOI: 10.1007/s11418-015-0907-7

Source DB:  PubMed          Journal:  J Nat Med        ISSN: 1340-3443            Impact factor:   2.343


  25 in total

Review 1.  Amphipathic lipid metabolites and their relation to arrhythmogenesis in the ischemic heart.

Authors:  S D DaTorre; M H Creer; S M Pogwizd; P B Corr
Journal:  J Mol Cell Cardiol       Date:  1991-02       Impact factor: 5.000

2.  Interaction of spin-labeled lysophosphatidylcholine with rabbit erythrocytes.

Authors:  H Utsumi; K Inoue; S Nojima; T Kwan
Journal:  Biochemistry       Date:  1978-05-16       Impact factor: 3.162

3.  A new approach to the development of anti-ischemic drugs. Substances that counteract the deleterious effect of lysophosphatidylcholine on the heart.

Authors:  H Hashizume; A N Hoque; K Magishi; A Hara; Y Abiko
Journal:  Jpn Heart J       Date:  1997-01

4.  Mechanism of lysophosphatidylcholine accumulation in the ischemic canine heart.

Authors:  T Mock; R Y Man
Journal:  Lipids       Date:  1990-07       Impact factor: 1.880

5.  Protective effects of dilazep and its derivative K-7259 on the haemolysis induced by amphiphiles in rat erythrocytes.

Authors:  A Hara; N Hayase; H Hashizume; Y Abiko
Journal:  J Pharm Pharmacol       Date:  1997-08       Impact factor: 3.765

Review 6.  Lysophospholipids, long chain acylcarnitines and membrane dysfunction in the ischaemic heart.

Authors:  P B Corr; J E Saffitz; B E Sobel
Journal:  Basic Res Cardiol       Date:  1987       Impact factor: 17.165

7.  Lysophosphatidylcholines containing polyunsaturated fatty acids were found as Na+, K+-ATPase inhibitors in acutely volume-expanded hog.

Authors:  M Tamura; T M Harris; K Higashimori; B J Sweetman; I A Blair; T Inagami
Journal:  Biochemistry       Date:  1987-05-19       Impact factor: 3.162

8.  Protective effects of quinaprilat and trandolaprilat, active metabolites of quinapril and trandolapril, on hemolysis induced by lysophosphatidylcholine in human erythrocytes.

Authors:  Nobumasa Hayase; Machiko Satomi; Akiyoshi Hara; Toshio Awaya; Keiko Shimizu; Kazuo Matsubara
Journal:  Biol Pharm Bull       Date:  2003-05       Impact factor: 2.233

9.  Effects of palmitoyl carnitine and LPC on cardiac sarcolemmal Na+-K+-ATPase.

Authors:  B J Pitts; C H Okhuysen
Journal:  Am J Physiol       Date:  1984-11

10.  Lipid alterations induced by renal ischemia: pathogenic factor in membrane damage.

Authors:  E Matthys; Y Patel; J Kreisberg; J H Stewart; M Venkatachalam
Journal:  Kidney Int       Date:  1984-08       Impact factor: 10.612

View more
  1 in total

1.  Design of Non-Haemolytic Nanoemulsions for Intravenous Administration of Hydrophobic APIs.

Authors:  Line Séguy; Anne-Claire Groo; Didier Goux; Didier Hennequin; Aurélie Malzert-Fréon
Journal:  Pharmaceutics       Date:  2020-11-25       Impact factor: 6.321

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.